Genopole

What Genopole does

Genopole is France's first and leading biocluster, structured as a Groupement d'Intérêt Public (GIP) — a public-private partnership — established in 1998 in Évry-Courcouronnes, 30 km south of Paris. The organization operates an integrated innovation campus spanning 11.5 hectares and 115,000 m² of scientific research infrastructure, hosting 78 biotech companies, 16 academic laboratories, and 23 shared technology platforms that collectively serve approximately 2,400 researchers, entrepreneurs, students, and staff. Genopole structures and animates a genomics and life sciences research hub, supports the growth of innovative biotech enterprises, and reinforces life sciences education via Université d'Évry Paris-Saclay on the campus, with activity organized around three strategic sectors: innovative therapies, industrial biotechnologies, and digital genomics.

Genopole's core technology offering comprises 23 mutualized platforms spanning cellular biology and imaging, molecular biology, structural biology and analytical chemistry, bioproduction, biological resource centers, functional exploration, bioinformatics, and robotics/automation. Specific platforms include GATEX (pilot-scale bioproduction with Techfors-S 10L and 32L bioreactors), Protopia (precision fermentation formulation), MicroScope (microbial genome annotation and comparative phylogenetic analysis), EVRYRNA (non-coding RNA prediction and analysis), OCCIGen (imaging cytometry), and the REVE very high-speed broadband network linking 14 scientific sites across the Évry agglomeration. Genopole runs four main accompaniment programs: Shaker (6-month pre-incubation with shared lab and reagent funding), Gene.iO (1-year early-stage startup acceleration for first funding or commercial agreements), ATIGe (3-year research team creation with €250,000 in funding per team), and Upscale Bio (growth acceleration), complemented by the L'Oréal Green Sciences Incubator @Genopole co-incubation program providing two fully equipped labs.

Genopole's revenue model is anchored in institutional funding from the French State, Île-de-France Region, Essonne Department, Grand Paris Sud agglomeration, City of Évry-Courcouronnes, and AFM-Téléthon, supplemented by service revenues from technology platform access, real estate operations through its wholly-owned subsidiary SEM Genopole, incubation program participation, and co-incubation partnerships. The organization is not venture-backed, has no external equity investors, and operates under shared governance among institutional stakeholders. Its convention was renewed for 9 years in February 2026, with INRAE and CNRS joining as new members, reinforcing its long-term role in French biotech sovereignty and unlocking continued public funding under the France 2030 plan.

Name

Genopole

Legal name

GIP Genopole

Website

http://www.genopole.fr

Company type

Private

Founded year

1998

Operating status

Operating

Headcount range

11–50 employees

Short description

Genopole is France's leading biocluster, a public-private partnership operating an integrated biotech campus in Évry-Courcouronnes that hosts 78 companies, 16 laboratories, and 23 technology platforms supporting startups, researchers, and academic institutions in genomics and life sciences.

Ownership category

akta.pro rank

Product category

Biotechnology Innovation Ecosystem (Biocluster Services)

NAICS

Research and Development in Biotechnology (except Nanobiotechnology) (541714)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Bioprocess Development & Scale-Up/Scale-Down Platforms (DoE, high-throughput, modeling) (HLAAAJAF)

akta.pro secondary industries

Process Development & Tech Transfer Services (upstream/downstream) (HLAAAKAF), Cell Culture & Bioprocess Lab Equipment (Bioreactors, Single-Use Systems, Controllers) (HLAGAIAG), Biofuel Plant EPC, O&M & Process Technology Providers (EUAAAHAK), Bio-based Solvents & Process Chemicals (e.g., bio-acetone, bio-butanol, bio-IPA, green solvents) (EUAAAIAB)

Keywords

• Biocluster ecosystem
• Biotech incubation
• Bioproduction infrastructure
• Genomics platforms
• Research acceleration

Headquarters

HQ city

Évry

HQ country

France

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Infrastructure, Operations, Technology or R&D, Marketing or Sales

Revenue model

1. Public Funding and Subsidies: Genopole is a GIP (Groupement d'Intérêt Public) primarily supported by government funding including the French State, Île-de-France Region, Essonne Department, Grand Paris Sud agglomeration, Evry-Courcouronnes City, and AFM-Téléthon
2. Incubation and Support Services: Provides incubation, support programs (Shaker, Gene.iO, ATIGe, Upscale Bio), real estate services, and technology platform access to biotech companies and researchers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels4 records

Core offering

Genopole operates as France's first biocluster, an integrated innovation ecosystem dedicated to biotechnology and life sciences. It delivers four main lines of offerings: (1) structured incubation and acceleration programs (Shaker, Gene.iO, ATIGe, Upscale Bio) that support biotech startups from idea inception through growth; (2) shared access to 23 mutualized technology platforms spanning genomics, bioproduction, imaging, bioinformatics, and structural biology; (3) physical infrastructure including the GATEX bioproduction facility, Protopia precision fermentation laboratory, and real estate/laboratory space on the 11.5-hectare Evry-Courcouronnes campus; and (4) business support services including European funding assistance, international development, training programs, and corporate co-incubation (e.g., L'Oréal Green Sciences Incubator).

Product overview

Genopole is France's leading biocluster - an integrated innovation ecosystem combining incubation/acceleration programs (Shaker, Gene.iO, ATIGe, Upscale Bio), shared technology platforms (GATEX bioproduction, Protopia prototyping, bioinformatics tools, imaging/cytometry, genomics sequencing), and business support services. The ecosystem supports 78 companies, 16 laboratories, and 23 shared platforms across three strategic sectors: innovative therapies, industrial biotechnologies, and digital genomics. Genopole provides physical infrastructure (real estate, laboratories), funding assistance, training programs, and international development support to biotech startups and researchers.

Differentiator

Problem solved

Functional benefit

Brands

• SEM Genopole: Société d'Économie Mixte (SEM) Genopole — the real estate management and property services entity of the Genopole biocluster campus, directed by David Bodet.
• Shaker
• Gene.iO
• ATIGe
• Upscale Bio
• GATEX
• Protopia
• UX CARE
• D4MedTech
• D4Gen Hackathon
• Genopole Partnering Week
• L'Oréal Green Sciences Incubator @Genopole

Products and services

• Shaker Program
• Gene.iO Program
• ATIGe Program

Quantifiable outcome

• Nearly 70% of Shaker program participants have created a startup
• +2 more outcomes

Named customers3 records

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability9 records

Feature3 records

Partnerships

Six partnerships are on record, tiered regional and core.

• Kawasaki Institute of Industrial Promotion (KIIP)regionalStrategic or Co-development Partner · 1 February 20263-year partnership to strengthen Franco-Japanese collaborations in biotechnology and advanced therapies. Japanese delegation visited Genopole ecosystem including Abolis, Généthon, and I-STEM institute.
• PUI Innovation Alliance Université Paris-SaclaycoreStrategic or Co-development Partner · 1 January 2026Genopole joined as founding member of the PUI Innovation Alliance Université Paris-Saclay, a structuring program funded by France 2030 to accelerate technology transfer and deeptech startup emergence.
• ARD (Alliance pour la Recherche et le Développement)coreStrategic or Co-development Partner · 23 June 2025Partnership to accelerate industrialization of biotechnologies in France. Aims to create a continuum between research, biofoundry and biomanufacturing, strengthening the French bioeconomy sector.
• Université Paris-SaclaycoreStrategic or Co-development Partner · 12 January 2024Strategic partnership to strengthen collaboration in biotechnology innovation. Genopole is the biotechnology actor of the scientific and technological pole of Paris-Saclay.
• GenoThercoreStrategic or Co-development Partner · 16 May 2023Biocluster project labeled under France 2030 including Généthon, Genopole, AP-HP, Inserm, Université d'Evry Paris-Saclay, Spark Therapeutics, Yposkesi. Focus on gene therapy industrialization.
• L'Oréal Green Sciences Incubator @GenopolecoreStrategic or Co-development Partner · 17 April 2023Co-incubation program where startups receive scientific support (two fully equipped labs with L'Oréal experts) and business acceleration (fundraising, market access, partnerships, communication). First incubated: Algentech and Novobiom.

Scale indicators8 records

Recent moves15 records

Expansion highlights6 records

Direct peers

• BioGenerator: St. Louis-based nonprofit startup creator and investor specialized in bioscience company formation. Comparable to Genopole's ATIGe and Shaker programs in early-stage biotech venture creation.
• BioEnterprise (Cleveland): US Midwest life sciences accelerator supporting biotech and medical device startups through infrastructure and partnerships. Comparable to Genopole in the regional biotech cluster model.
• MaRS Discovery District: Toronto-based innovation hub combining startup incubation, lab infrastructure, and corporate partnerships across health, biotech, and clean tech. Directly comparable to Genopole as a public-purpose biocluster anchoring university research and biotech scale-up.
• JLABS (Johnson & Johnson Innovation): Johnson & Johnson's global network of life-science incubators providing lab facilities, mentorship, and corporate partnership access to biotech startups. Comparable in providing shared infrastructure and corporate-anchored incubation.
• One Nucleus (UK): Life sciences and healthcare membership organization in the UK operating in the Cambridge/London cluster, providing networking, training, and infrastructure support. Comparable in serving as a regional biotech ecosystem anchor.
• BioM (Munich Biotech Cluster): Germany's leading biotech cluster management organization, supporting startups, infrastructure, and academic-industrial collaboration in Bavaria. Direct European peer in the biocluster operating model.
• Medicen Paris Region: French competitiveness cluster focused on health, biotech, and medtech innovation in Île-de-France. Directly competes with Genopole for French biotech startups, public funding, and corporate partnerships.
• Karolinska Innovations: Innovation hub commercializing research from Karolinska Institutet in Sweden's biotech cluster. Comparable in the university-anchored biotech incubation model.

Regional players

• Station F: Paris-based mega-incubator with a biotech program track. Same geography as Genopole, partially overlapping in startup support, but broader (tech-focused) and lacking Genopole's dedicated bioproduction platforms.

Broad incumbents

• CIC (Cambridge Innovation Center): Large US operator of shared innovation campuses including wet-lab and biotech space. Broader in scope (multi-sector) but directly comparable in delivering shared lab infrastructure and incubation services.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• Facebookfacebook.com/genopole-r
• LinkedInlinkedin.com/company/genopole
• Xx.com/Genopole

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments2 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Genopole